China Ready to Increase Imports from Germany and Europe

China is expanding imports from Germany and the rest of Europe to increase access to high-quality goods and pharmaceutical innovation, according to Ling Ji, China’s vice minister of commerce. During a Berlin event, Ling stated the move aims to leverage the Chinese consumer market and foster complementary economic ties, with Bayer AG identifying China as a critical driver for global pharmaceutical portfolios.

Why is China increasing imports of German health and industrial products?

The initiative, titled “Great Market for All: Exporting to China,” seeks to create efficient channels for high-quality German products to enter the Chinese market. Ling Ji stated that China and Germany have long followed a policy of openness and mutual respect to integrate their industries.

According to Ling, the demand for premium consumer goods and advanced industrial products from Germany continues to grow. He noted that while Germany has expressed concerns over trade imbalances, achieving a balanced bilateral relationship is “only a matter of time” if both parties remain open.

Did You Know? The China International Import Expo (CIIE) has seen participation from 151 countries, regions, and international organizations, with Germany ranking first in Europe for both exhibition space and the number of participating companies, according to Li Guoqing.

How does this impact pharmaceutical innovation?

Stefan Oelrich, head of the pharmaceutical division at Bayer AG, stated that China is no longer viewed solely as a large market. He described the country as a “motor of innovation” that directly feeds the company’s global portfolio.

Talk: China's acquisitions in Europe | Made in Germany

Oelrich noted that staying at the forefront of the pharmaceutical industry requires presence where innovation occurs. He identified China as one of the most important locations for this development to maintain global competitiveness.

Expert Insight: Samantha Carter suggests that the synergy between German mechanical engineering and China’s speed in AI and big data application could accelerate the development of smart manufacturing in health tech. This combination may reduce the time it takes to move medical hardware from prototype to mass-market application.

What may happen next for China-Germany cooperation?

Future cooperation could deepen in high-tech sectors including artificial intelligence, industrial automation, and green technology. Eberhard J. Trempel, director general of the Berlin Global Trade Forum, noted significant potential for synergy in decarbonization and autonomous driving.

Thomas Koenig of the German Chamber of Commerce and Industry stated that despite global trade tensions, a considerable margin for cooperation remains. He suggested that expanding exports to China may contribute to a more resilient and balanced economic relationship.

Frequently Asked Questions

What is the “Great Market for All: Exporting to China” initiative?
Presented in Shanghai in November 2025, it is a program where the Chinese Ministry of Commerce selects five to eight partner countries annually to organize over 100 activities designed to increase imports.

How does Bayer AG view China’s role in the health sector?
According to Stefan Oelrich, China is a key source of innovation and a primary engine that fuels Bayer AG’s global pharmaceutical portfolio.

What sectors are identified for future synergistic cooperation?
Eberhard J. Trempel identified infrastructure, green technology, decarbonization, autonomous driving, AI, and industrial automation as areas with high potential.

How do you think increased international collaboration in AI will change the future of healthcare?